[1] |
CHE Xuanlin, SU Juan, CHEN Mingliang.
Acquired hemophilia associated with bullous pemphigus: a case report
[J]. China Journal of Leprosy and Skin Diseases, 2022, 38(2): 110-111.
|
[2] |
YAO Xiangjun, ZHANG Qi, WANG Ting, FAN Min, LUO Zhen, WANG Peiguang, WANG Zaixing.
Clinical features and etiological analysis of skin infection in 656 hospitalized patients with autoimmune bullous disease
[J]. China Journal of Leprosy and Skin Diseases, 2021, 37(8): 494-498.
|
[3] |
XUE Xiaotong, SUN Yonghu, ZHOU Guizhi, ZHANG Furen.
Localized bullous pemphigoid around the eyes: a case report
[J]. China Journal of Leprosy and Skin Diseases, 2021, 37(7): 456-458.
|
[4] |
SUN Feifei, LIU Hong, ZHOU Guizhi, LIU Yongxia, SHI Zhongxiang, ZHANG Furen.
Amyloidosis pemphigoid: a case report
[J]. China Journal of Leprosy and Skin Diseases, 2021, 37(12): 772-774.
|
[5] |
FANG Xiaokai, SUN Yonghu, ZHOU Guizhi, YANG Baoqi, ZHANG Furen.
Nonbullous pemphigoid: a case report
[J]. China Journal of Leprosy and Skin Diseases, 2021, 37(11): 719-721.
|
[6] |
MENG Weiwei, XIA Qi.
Levels of SOCS-1 and SOCS-3 in serum and bullous fluid of the patients with bullous pemphigoid
[J]. China Journal of Leprosy and Skin Diseases, 2020, 36(7): 390-393.
|
[7] |
YAO Xiangjun, WANG Zaixing.
Update of pemphigoid nodularis
[J]. China Journal of Leprosy and Skin Diseases, 2020, 36(3): 182-184.
|
[8] |
YANG Baoqi, ZHANG Zhaoxia, CHEN Mingfei, WANG Na, YAN Xiaoxiao, YANG Qing, PAN Futang, WANG Guangjin, DU Donghong, WU Mei, SHI Zhongxiang, ZHANG Furen.
Treatment of pemphigus with rituximab: report of six cases and literature review
[J]. China Journal of Leprosy and Skin Diseases, 2020, 36(12): 718-721.
|
[9] |
XUE Xiaotong, SUN Yonghu, ZHOU Guizhi, ZHANG Furen.
Pemphigoid nodularis: a case report and literature review
[J]. China Journal of Leprosy and Skin Diseases, 2020, 36(12): 737-740.
|
[10] |
SUN Feifei, YANG Baoqi.
Update of biological agents and bioengineering technology in treatment of pemphigus
[J]. China Journal of Leprosy and Skin Diseases, 2020, 36(12): 764-768.
|
[11] |
WANG Zihong, BAI Bingxue.
Research progress of thebiologicals for treating atopic dermatitis
[J]. China Journal of Leprosy and Skin Diseases, 2019, 35(7): 445-448.
|
[12] |
WANG Zhe, SUN Yonghu, ZHOU Guizhi, ZHANG Furen.
Nonbullous pemphigoid: two cases report and literature review
[J]. China Journal of Leprosy and Skin Diseases, 2019, 35(5): 284-286.
|
[13] |
LI Xiuxiu, WANG Peiguang.
Update of study on the treatment of pemphigus
[J]. China Journal of Leprosy and Skin Diseases, 2019, 35(12): 757-761.
|
[14] |
CAO Shan, WANG Na, YAN Xiaoxiao, ZHANG Zhaoxia, ZHOU Shengji, WANG Guangjin, DU Donghong, YANG Qing, YU Changping, ZHOU Guizhi, YANG Baoqi, ZHANG Furen.
Clinical analysis of 10 patients with psoriasis vulgaris complicated with bullous pemphigoid
[J]. China Journal of Leprosy and Skin Diseases, 2019, 35(11): 643-646.
|
[15] |
WANG Yaru, LI Hongjun, XU Dezhi, WANG Jianwen, ZHOU Guizhi, YANG Baoqi.
Anti-BP180 and 230 antibodies in 131 patients with neurological diseases
[J]. China Journal of Leprosy and Skin Diseases, 2018, 34(5): 257-260“264.
|